Chemoembolization with Drug-Eluting Beads Complicated by Intrahepatic Biloma

ABSTRACT

Chemoembolization with drug-eluting beads is a type of locoregional therapy currently being used for the treatment of hepatocellular carcinoma and metastatic disease to the liver. This treatment has proven effectiveness in controlling tumor growth, extending survival time, and improving quality of life. Chemoembolization with drug-eluting beads have been shown to be safe, but like any other invasive procedure, can have associated complications. The authors present a case of intrahepatic biloma formation occurring as a result of treatment with drug-eluting beads.

KEYWORDS

Biloma - drug-eluting beads - DEBs - chemoembolization

REFERENCES

• 1 Llovet J M, Beaugrand M. Hepatocellular carcinoma: present status and future prospects.  J Hepatol. 2003;  38 (Suppl 1) S136-S149
• 2 Martin R C, Robbins K, Tomalty D et al.. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.  World J Surg Oncol. 2009;  7 80
• 3 Llovet J M, Real M I, Montaña X Barcelona Liver Cancer Group et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.  Lancet. 2002;  359 (9319) 1734-1739
• 4 Lo C M, Ngan H, Tso W K et al.. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.  Hepatology. 2002;  35 (5) 1164-1171
• 5 Tang Y, Taylor R R, Gonzalez M V, Lewis A L, Stratford P W. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.  J Control Release. 2006;  116 (2) e55-e56
• 6 Taylor R R, Tang Y, Gonzalez M V, Stratford P W, Lewis A L. Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.  Eur J Pharm Sci. 2007;  30 (1) 7-14
• 7 Aliberti C, Tilli M, Benea G, Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.  Anticancer Res. 2006;  26 (5B) 3793-3795
• 8 Fiorentini G, Aliberti C, Turrisi G et al.. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.  In Vivo. 2007;  21 (6) 1085-1091
• 9 Martin R C, Joshi J, Robbins K, Tomalty D, O'Hara R, Tatum C. Transarterial chemoembolization of metastatic colorectal carcinoma with drug-eluting beads, irinotecan (DEBIRI): multi-institutional registry.  J Oncol. 2009;  2009 539-545
• 10 Lammer J, Malagari K, Vogl T et al. Prospective randomized study of doxorubicin-eluting bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION V Study.  Cardiovasc Intervent Radiol. 2010;  33 (1) 41-52
• 11 Martin RCG, Howard J, Tomalty D et al.. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.  Cardiovasc Intervent Radiol. 2010;  33 (5) 960-966
• 12 Winick A B, Waybill P N, Venbrux A C. Complications of percutaneous transhepatic biliary interventions.  Tech Vasc Interv Radiol. 2001;  4 (3) 200-206
• 13 Dondelinger R F, Kurdziel J C, Gathy C. Percutaneous treatment of pyogenic liver abscess: a critical analysis of results.  Cardiovasc Intervent Radiol. 1990;  13 (3) 174-182
• 14 Huang C K, Chen S C, Shih PMC, Chuang W L. Biloma following transcatheter arterial chemoembolization with microspheres: a case report.  Kaohsiung J Med Sci. 2007;  23 (9) 470-474
• 15 Touzios J G, Kiely J M, Pitt S C et al.. Neuroendocrine hepatic metastases: does aggressive management improve survival?.  Ann Surg. 2005;  241 (5) 776-783, discussion 783–785
• 16 Sakamoto I, Iwanaga S, Nagaoki K et al.. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization.  AJR Am J Roentgenol. 2003;  181 (1) 79-87
• 17 Kim H K, Chung Y H, Song B C et al.. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma.  J Clin Gastroenterol. 2001;  32 (5) 423-427
• 18 Xia J, Ren Z, Ye S et al.. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.  Eur J Radiol. 2006;  59 (3) 407-412
• 19 Akahane M, Koga H, Kato N et al.. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management.  Radiographics. 2005;  25 (Suppl 1) S57-S68
• 20 Kemeny N E, Niedzwiecki D, Hollis D R et al.. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).  J Clin Oncol. 2006;  24 (9) 1395-1403
• 21 Alazmi W M, McHenry L, Watkins J L et al.. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.  J Clin Gastroenterol. 2006;  40 (4) 353-357
• 22 Shea Jr W J, Demas B E, Goldberg H I, Hohn D C, Ferrell L D, Kerlan R K. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation.  AJR Am J Roentgenol. 1986;  146 (4) 717-721
• 23 Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.  Ann Intern Med. 1987;  107 (4) 459-465
• 24 Minagawa M, Makuuchi M, Torzilli G et al.. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.  Ann Surg. 2000;  231 (4) 487-499
• 25 Xia J, Ren Z, Ye S et al.. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.  Eur J Radiol. 2006;  59 (3) 407-412
• 26 Kuroda C, Iwasaki M, Tanaka T et al.. Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study.  Radiology. 1983;  149 (1) 85-89
• 27 Shankar S, vanSonnenberg E, Silverman S G, Tuncali K, Morrison P R. Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases.  AJR Am J Roentgenol. 2003;  181 (2) 475-477
• 28 Sicklick J K, Camp M S, Lillemoe K D et al.. Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients.  Ann Surg. 2005;  241 (5) 786-792, discussion 793–795
• 29 Atassi B, Bangash A K, Lewandowski R J et al.. Biliary sequelae following radioembolization with Yttrium-90 microspheres.  J Vasc Interv Radiol. 2008;  19 (5) 691-697
• 30 Chen M J, Lin C C, Chang W H, Yang F S. Biloma following repeated transcatheter arterial embolization and complicated by intrahepatic duct stones: a case report.  World J Gastroenterol. 2005;  11 (30) 4764-4765
• 31 Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus.  Am J Gastroenterol. 1993;  88 (9) 1410-1415
• 32 Miyayama S, Yamashiro M, Okuda M et al.. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma.  Cardiovasc Intervent Radiol. 2010;  33 (6) 1168-1179
• 33 Vazquez J L, Thorsen M K, Dodds W J et al.. Evaluation and treatment of intraabdominal bilomas.  AJR Am J Roentgenol. 1985;  144 (5) 933-938
• 34 Chen X P, Peng S Y, Peng C H et al.. A ten-year study on non-surgical treatment of postoperative bile leakage.  World J Gastroenterol. 2002;  8 (5) 937-942
• 35 Shankar S, vanSonnenberg E, Silverman S G, Tuncali K, Morrison P R. Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases.  AJR Am J Roentgenol. 2003;  181 (2) 475-477
• 36 Nuñez Jr D, Becerra J L, Martin L C. Subhepatic collections complicating laparoscopic cholecystectomy: percutaneous management.  Abdom Imaging. 1994;  19 (3) 248-250
• 37 Sammak B M, Yousef B A, Gali M H, al Karawi M A, Mohamed A E. Case report: radiological and endoscopic management of bile leak following laparoscopic cholecystectomy.  J Gastroenterol Hepatol. 1997;  12 (1) 34-38
• 38 Kuligowska E, Schlesinger A, Miller K B, Lee V W, Grosso D. Bilomas: a new approach to the diagnosis and treatment.  Gastrointest Radiol. 1983;  8 (3) 237-243
• 39 Walker A T, Shapiro A W, Brooks D C, Braver J M, Tumeh S S. Bile duct disruption and biloma after laparoscopic cholecystectomy: imaging evaluation.  AJR Am J Roentgenol. 1992;  158 (4) 785-789
• 40 Brady P G, Pinkas H, Pencev D. Endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy.  Dig Dis. 1996;  14 (6) 371-381